ACAD
ACADIA Pharmaceuticals Inc
Price:  
15.54 
USD
Volume:  
2,585,510.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Acadia WACC - Weighted Average Cost of Capital

The WACC of ACADIA Pharmaceuticals Inc (ACAD) is 7.5%.

The Cost of Equity of ACADIA Pharmaceuticals Inc (ACAD) is 10.00%.
The Cost of Debt of ACADIA Pharmaceuticals Inc (ACAD) is 5.00%.

Range Selected
Cost of equity 8.10% - 11.90% 10.00%
Tax rate 0.30% - 0.70% 0.50%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.5% - 8.4% 7.5%
WACC

Acadia WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.91 1.26
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.10% 11.90%
Tax rate 0.30% 0.70%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.5% 8.4%
Selected WACC 7.5%